BioMarin Pharmaceutical Inc. logo BMRN - BioMarin Pharmaceutical Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 28
HOLD 13
SELL 0
STRONG
SELL
0
| PRICE TARGET: $89.93 DETAILS
HIGH: $120.00
LOW: $50.00
MEDIAN: $95.00
CONSENSUS: $89.93
UPSIDE: 66.26%
AlphaQuality

AlphaQuality

Quantitative six-pillar business-quality grade

Platform & Compounding FCF

AlphaQuality — archetype-weighted quantitative grade

B- 67.8 / 100 composite

Composite Grade

Composite of six pillars weighted for platform & compounding fcf businesses. Purely quantitative — no stock price or analyst input.

Profitability

Weight: 25%
C- 47.2
  • 5yr Avg ROIC 2.9% 25/100
  • Operating Margin Trend +5.13 pp/yr 100/100
Contributes 11.8 pts toward composite.

Capital Efficiency

Weight: 15%
D- 29.1
  • 5yr Avg ROE 3.4% 27/100
  • 5yr Share-Count CAGR 1.9% 33/100
Contributes 4.4 pts toward composite.

Growth Quality

Weight: 25%
A 91.7
  • 5yr Revenue CAGR 14.9% 90/100
  • 5yr EPS CAGR 33.9% 100/100
  • Revenue-Growth Years (5) 4/5 80/100
Contributes 22.9 pts toward composite.

Cash Generation

Weight: 20%
A- 84.1
  • 5yr FCF Margin 10.9% 72/100
  • 5yr FCF/NI Conversion 0.99x 99/100
Contributes 16.8 pts toward composite.

Balance Sheet

Weight: 10%
A+ 97.8
  • Net Debt / EBITDA -1.60x 100/100
  • Interest Coverage (EBIT/Int) 45.27x 100/100
  • Altman Z-Score 3.75 91/100
Contributes 9.8 pts toward composite.

Stability

Weight: 5%
D+ 41.2
  • EPS Volatility (σ/μ) 0.75 10/100
  • Piotroski F-Score 5 56/100
  • Negative-Revenue Years (5) 1/5 80/100
Contributes 2.1 pts toward composite.

Guru Flow

Curated superinvestor sentiment — not part of the AlphaQuality grade.
Holding

5 of 5 gurus held; 2 added; 3 trimmed.

Holders
5
Avg Δ position
+53.0%
New buys
0
Full exits
0
As of Q1 2026
How this is calculated

AlphaQuality grades six pillars from 0-100 and weights each by archetype:

  • Profitability (25%) — 5yr Avg ROIC, Operating Margin Trend
  • Capital Efficiency (15%) — 5yr Avg ROE, 5yr Share-Count CAGR
  • Growth Quality (25%) — 5yr Revenue CAGR, 5yr EPS CAGR, Revenue-Growth Years (5)
  • Cash Generation (20%) — 5yr FCF Margin, 5yr FCF/NI Conversion
  • Balance Sheet (10%) — Net Debt / EBITDA, Interest Coverage (EBIT/Int), Altman Z-Score
  • Stability (5%) — EPS Volatility (σ/μ), Piotroski F-Score, Negative-Revenue Years (5)

We deliberately ignore stock price, analyst targets, and consensus ratings so the grade is suitable for backtesting forward returns. A minimum of 5 fiscal years of audited statements is required; distressed and highly leveraged infrastructure businesses are declared ungradable rather than forced into a numeric score.